JC

James Calloway

Financial Reporter

James Calloway is a financial reporter at StockTi covering corporate earnings, regulatory policy, and market-moving events. A former business journalist with Reuters, James has covered financial markets for over eight years across New York and Washington. He specializes in breaking down earnings reports, SEC filings, and policy decisions that affect publicly traded companies and investor portfolios.

Earnings, Regulation 908 articles

Articles by James Calloway

RELX Shares Approach Annual Low Amid AI Concerns Ahead of Earnings
Earnings

RELX Shares Approach Annual Low Amid AI Concerns Ahead of Earnings

RELX shares fell nearly 3% in early London trading, nearing a 52-week low as investors await annual results. The decline reflects broader anxiety over AI's impact on data and analytics firms.

RELX
BAT Chair Term Extended Ahead of Key Earnings Report
Earnings

BAT Chair Term Extended Ahead of Key Earnings Report

British American Tobacco shares gained 0.6% after the board extended Chair Luc Jobin's tenure to April 2028. Investors await the company's annual results, due Thursday.

BTI
Unilever Faces Valuation Test Ahead of Earnings Following Deutsche Bank Downgrade
Earnings

Unilever Faces Valuation Test Ahead of Earnings Following Deutsche Bank Downgrade

Unilever shares rose 1.53% to 5,244p despite a Deutsche Bank downgrade to 'hold' on valuation concerns. The consumer goods giant reports Q4 and full-year 2025 results on Feb. 12.

UL
NatWest Shares Under Pressure Ahead of Earnings Amid Wealth Deal Scrutiny
Earnings

NatWest Shares Under Pressure Ahead of Earnings Amid Wealth Deal Scrutiny

NatWest shares fell 2.4% to 605p as investors assess the impact of its £2.7 billion Evelyn Partners acquisition ahead of Friday's annual results.

BCS
GSK's RSV Vaccine Advances in Chinese Regulatory Review, Eyes 2027 Decision
Regulation

GSK's RSV Vaccine Advances in Chinese Regulatory Review, Eyes 2027 Decision

GSK's Arexvy RSV vaccine application has been accepted for review by China's drug regulator, with a potential approval decision expected in 2027. The stock edged higher as JPMorgan raised its price target and the company's dividend ex-date approaches.

GSK PFE JPM
Barclays Initiates £1 Billion Buyback Amid Profit Growth and U.S. Fee Concerns
Earnings

Barclays Initiates £1 Billion Buyback Amid Profit Growth and U.S. Fee Concerns

Barclays has commenced a £1 billion share repurchase program following a 12% rise in annual pretax profit, while investors monitor regulatory risks to its U.S. card operations.

BCS
AppLovin Shares Gain Ahead of Q4 Report Amid Analyst Target Adjustments
Earnings

AppLovin Shares Gain Ahead of Q4 Report Amid Analyst Target Adjustments

AppLovin's stock advanced 2.7% in extended trading Tuesday, continuing a rebound as investors await quarterly results. UBS trimmed its price target but maintained a Buy rating, citing strength in the company's ad technology.

APP
Meta Shares Dip Amid Regulatory Pressure in Germany and India
Regulation

Meta Shares Dip Amid Regulatory Pressure in Germany and India

Meta Platforms stock declined roughly 1% in after-hours trading following a German court ruling ordering a €30 million payment to Deutsche Telekom and India's new three-hour content removal mandate.

META
Robinhood Braces for Post-Earnings Volatility as Options Signal Major Move
Earnings

Robinhood Braces for Post-Earnings Volatility as Options Signal Major Move

Options markets are pricing in a potential double-digit swing for Robinhood shares following its Q4 earnings report, with analysts upgrading the stock amid a crypto-driven selloff.

HOOD
Reddit Shares Surge 5% as Analysts Recalibrate Following Strong Q4
Earnings

Reddit Shares Surge 5% as Analysts Recalibrate Following Strong Q4

Reddit stock climbed over 5% in afternoon trading, defying a flat broader market, as Wall Street analysts adjusted price targets following last week's robust earnings report and a new $1 billion share buyback authorization.

RDDT META PINS SNAP SPY QQQ
DoorDash Shares Edge Lower Ahead of Q4 Earnings Amid Economic Uncertainty
Earnings

DoorDash Shares Edge Lower Ahead of Q4 Earnings Amid Economic Uncertainty

DoorDash stock declined slightly as investors await the company's upcoming earnings report, with attention on consumer demand and margins against a backdrop of flat retail sales and pending economic data.

DASH UBER
Home Depot Shares Gain Ahead of Earnings as Investors Eye Housing Demand
Earnings

Home Depot Shares Gain Ahead of Earnings as Investors Eye Housing Demand

Home Depot stock advanced 2.6% to $390.84, outpacing a flat S&P 500, as investors rotated into consumer stocks following soft retail sales data. The focus now shifts to the company's quarterly report on February 24.

HD LOW SPY